Literature DB >> 24377042

Entire hemithorax irradiation for Masaoka stage IVa thymomas.

André Soares1, Luís Vasco Louro1, Marta Almeida2, Olga Sousa1.   

Abstract

Thymomas are rare neoplasms that have an indolent growth with a preferentially intra-thoracic dissemination pattern. Surgery is currently the standard treatment of thymomas; however radiotherapy is often used in an adjuvant setting due to a high sensitivity of these tumors to such treatment. Postoperative entire hemithoracic irradiation has been used in selected Masaoka stage IVa cases after complete surgical excision of metastatic lesions. In the present article, the authors report three cases of Masaoka stage IVa thymoma that underwent entire hemithorax irradiation after surgical excision of metastatic lesions. The first two patients presented as stage IVa thymomas. The third case consisted of a pleural recurrence of a thymoma. Hemithoracic irradiation with low doses has been used by different authors; the available data shows that it is a well-tolerated treatment that could potentially lead to better loco-regional control and increased overall survival.

Entities:  

Keywords:  Hemithoracic; Radiotherapy; Stage IVa; Thymoma

Year:  2012        PMID: 24377042      PMCID: PMC3863277          DOI: 10.1016/j.rpor.2012.05.004

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  24 in total

1.  Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma.

Authors:  Yasuko Hosaka; Masanori Tsuchida; Shin-ichi Toyabe; Hajime Umezu; Tadaaki Eimoto; Jun-ichi Hayashi
Journal:  Ann Thorac Surg       Date:  2010-03       Impact factor: 4.330

2.  Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment.

Authors:  Marco Lucchi; Roberta Ricciardi; Franca Melfi; Leonardo Duranti; Fulvio Basolo; Gerardo Palmiero; Luigi Murri; Alfredo Mussi
Journal:  Eur J Cardiothorac Surg       Date:  2009-02-23       Impact factor: 4.191

Review 3.  Management of thymomas.

Authors:  Cameron D Wright
Journal:  Crit Rev Oncol Hematol       Date:  2007-06-14       Impact factor: 6.312

Review 4.  Radiation therapy in the management of thymic tumors.

Authors:  Tony Y Eng; Charles R Thomas
Journal:  Semin Thorac Cardiovasc Surg       Date:  2005

Review 5.  Thymoma and thymic carcinoma.

Authors:  Federico Venuta; Marco Anile; Daniele Diso; Domenico Vitolo; Erino A Rendina; Tiziano De Giacomo; Federico Francioni; Giorgio Furio Coloni
Journal:  Eur J Cardiothorac Surg       Date:  2009-07-16       Impact factor: 4.191

6.  Feasibility of multimodality therapy including extended resections in stage IVA thymoma.

Authors:  James Huang; Nabil P Rizk; William D Travis; Venkatraman E Seshan; Manjit S Bains; Joseph Dycoco; Robert J Downey; Raja M Flores; Bernard J Park; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2007-10-26       Impact factor: 5.209

7.  Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease.

Authors:  Jeffrey A Forquer; Nan Rong; Achilles J Fakiris; Patrick J Loehrer; Peter A S Johnstone
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-05-08       Impact factor: 7.038

Review 8.  Radiotherapy for thymoma and thymic carcinoma.

Authors:  Clifton David Fuller; Douglas M Housman; Charles R Thomas
Journal:  Hematol Oncol Clin North Am       Date:  2008-06       Impact factor: 3.722

Review 9.  Optimal therapy for thymoma.

Authors:  Kazuya Kondo
Journal:  J Med Invest       Date:  2008-02

10.  Thymoma: Results of treatment and role of radiotherapy.

Authors:  Marcin Hetnał; Krzysztof Małecki; Magdalena Wolanin; Stanisław Korzeniowski; Tomasz Walasek
Journal:  Rep Pract Oncol Radiother       Date:  2010-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.